Israel's Teva gets China approval for Huntington's treatment - Chemdiv
Austedo (deutetrabenazine) for the Treatment of Chorea Associated with Huntington's Disease - Clinical Trials Arena
FDA approves first deuterated drug
Teva Announces Settlement with Lupin Resolving AUSTEDO® (deutetrabenazine) Patent Dispute
Teva announces FDA approval of Austedo tablets for chorea associated with huntington's disease - Pharma Advancement
Teva Launches 'It's Not OK - It's TD' National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia and AUSTEDO® ( deutetrabenazine) tablets
Deutetrabenazine Fails to Meet End Point in Tourette Syndrome Trials
FDA Requests More Data on Potential New Treatment for Huntington Disease
BUY Deutetrabenazine (Austedo) 6 mg/1 Teva Neuroscience, Inc.